ID AMPPA_METM6 Reviewed; 505 AA. AC A9A6M7; DT 14-APR-2009, integrated into UniProtKB/Swiss-Prot. DT 15-JAN-2008, sequence version 1. DT 27-MAR-2024, entry version 90. DE RecName: Full=AMP phosphorylase {ECO:0000255|HAMAP-Rule:MF_02132}; DE Short=AMPpase {ECO:0000255|HAMAP-Rule:MF_02132}; DE EC=2.4.2.57 {ECO:0000255|HAMAP-Rule:MF_02132}; DE AltName: Full=Nucleoside monophosphate phosphorylase {ECO:0000255|HAMAP-Rule:MF_02132}; DE Short=NMP phosphorylase {ECO:0000255|HAMAP-Rule:MF_02132}; GN OrderedLocusNames=MmarC6_0624; OS Methanococcus maripaludis (strain C6 / ATCC BAA-1332). OC Archaea; Euryarchaeota; Methanomada group; Methanococci; Methanococcales; OC Methanococcaceae; Methanococcus. OX NCBI_TaxID=444158; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C6 / ATCC BAA-1332; RG US DOE Joint Genome Institute; RA Copeland A., Lucas S., Lapidus A., Barry K., Glavina del Rio T., Dalin E., RA Tice H., Pitluck S., Clum A., Schmutz J., Larimer F., Land M., Hauser L., RA Kyrpides N., Mikhailova N., Sieprawska-Lupa M., Whitman W.B., RA Richardson P.; RT "Complete sequence of Methanococcus maripaludis C6."; RL Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Catalyzes the conversion of AMP and phosphate to adenine and CC ribose 1,5-bisphosphate (R15P). Exhibits phosphorylase activity toward CC CMP and UMP in addition to AMP. Functions in an archaeal AMP CC degradation pathway, together with R15P isomerase and RubisCO. CC {ECO:0000255|HAMAP-Rule:MF_02132}. CC -!- CATALYTIC ACTIVITY: CC Reaction=AMP + phosphate = adenine + alpha-D-ribose 1,5-bisphosphate; CC Xref=Rhea:RHEA:36975, ChEBI:CHEBI:16708, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:68688, ChEBI:CHEBI:456215; EC=2.4.2.57; CC Evidence={ECO:0000255|HAMAP-Rule:MF_02132}; CC -!- CATALYTIC ACTIVITY: CC Reaction=CMP + phosphate = alpha-D-ribose 1,5-bisphosphate + cytosine; CC Xref=Rhea:RHEA:36987, ChEBI:CHEBI:16040, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:60377, ChEBI:CHEBI:68688; EC=2.4.2.57; CC Evidence={ECO:0000255|HAMAP-Rule:MF_02132}; CC -!- CATALYTIC ACTIVITY: CC Reaction=phosphate + UMP = alpha-D-ribose 1,5-bisphosphate + uracil; CC Xref=Rhea:RHEA:36991, ChEBI:CHEBI:17568, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:57865, ChEBI:CHEBI:68688; EC=2.4.2.57; CC Evidence={ECO:0000255|HAMAP-Rule:MF_02132}; CC -!- SIMILARITY: Belongs to the thymidine/pyrimidine-nucleoside CC phosphorylase family. Type 2 subfamily. {ECO:0000255|HAMAP- CC Rule:MF_02132}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; CP000867; ABX01441.1; -; Genomic_DNA. DR AlphaFoldDB; A9A6M7; -. DR SMR; A9A6M7; -. DR STRING; 444158.MmarC6_0624; -. DR KEGG; mmx:MmarC6_0624; -. DR eggNOG; arCOG02013; Archaea. DR HOGENOM; CLU_025040_6_0_2; -. DR OrthoDB; 9827at2157; -. DR PhylomeDB; A9A6M7; -. DR GO; GO:0004645; F:1,4-alpha-oligoglucan phosphorylase activity; IEA:InterPro. DR GO; GO:0016208; F:AMP binding; IEA:UniProtKB-UniRule. DR GO; GO:0016763; F:pentosyltransferase activity; IEA:UniProtKB-UniRule. DR GO; GO:0006196; P:AMP catabolic process; IEA:UniProtKB-UniRule. DR GO; GO:0046125; P:pyrimidine deoxyribonucleoside metabolic process; IEA:InterPro. DR GO; GO:0006206; P:pyrimidine nucleobase metabolic process; IEA:InterPro. DR Gene3D; 1.20.970.50; -; 1. DR Gene3D; 2.40.40.20; -; 1. DR Gene3D; 3.40.1030.10; Nucleoside phosphorylase/phosphoribosyltransferase catalytic domain; 1. DR Gene3D; 3.90.1170.30; Pyrimidine nucleoside phosphorylase-like, C-terminal domain; 1. DR HAMAP; MF_02132; AMP_phosphorylase; 1. DR InterPro; IPR017713; AMP_phosphorylase. DR InterPro; IPR000312; Glycosyl_Trfase_fam3. DR InterPro; IPR017459; Glycosyl_Trfase_fam3_N_dom. DR InterPro; IPR036320; Glycosyl_Trfase_fam3_N_dom_sf. DR InterPro; IPR035902; Nuc_phospho_transferase. DR InterPro; IPR036566; PYNP-like_C_sf. DR InterPro; IPR013102; PYNP_C. DR InterPro; IPR017872; Pyrmidine_PPase_CS. DR InterPro; IPR013466; Thymidine/AMP_Pase. DR InterPro; IPR000053; Thymidine/pyrmidine_PPase. DR NCBIfam; TIGR03327; AMP_phos; 1. DR NCBIfam; TIGR02645; ARCH_P_rylase; 1. DR PANTHER; PTHR10515; THYMIDINE PHOSPHORYLASE; 1. DR PANTHER; PTHR10515:SF0; THYMIDINE PHOSPHORYLASE; 1. DR Pfam; PF02885; Glycos_trans_3N; 1. DR Pfam; PF00591; Glycos_transf_3; 1. DR Pfam; PF07831; PYNP_C; 1. DR PIRSF; PIRSF000478; TP_PyNP; 1. DR SMART; SM00941; PYNP_C; 1. DR SUPFAM; SSF52418; Nucleoside phosphorylase/phosphoribosyltransferase catalytic domain; 1. DR SUPFAM; SSF47648; Nucleoside phosphorylase/phosphoribosyltransferase N-terminal domain; 1. DR SUPFAM; SSF54680; Pyrimidine nucleoside phosphorylase C-terminal domain; 1. DR PROSITE; PS00647; THYMID_PHOSPHORYLASE; 1. PE 3: Inferred from homology; KW Glycosyltransferase; Transferase. FT CHAIN 1..505 FT /note="AMP phosphorylase" FT /id="PRO_1000132352" FT ACT_SITE 258 FT /note="Proton donor" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" FT BINDING 170 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" FT BINDING 196..201 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" FT BINDING 205 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" FT BINDING 266 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" FT BINDING 290 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02132" SQ SEQUENCE 505 AA; 54713 MW; 2ADABA0720CE7C5C CRC64; MLFLNAKFID LDLGENAVIV NDEDLKGTSY YPQDRVLIES HAGAVIGNIY STKTMVKKGE VGMLVKELKE VSISEGEEVK LRHAEKPESI PFIKKKMDGQ VLNPHEIRTI IDEIVSKKLS NIELSAFVSS TYINGMNMDE ISEMTKRIAE TGDMISWEKS LVVDIHSIGG VPGNKYALLS IPILAAAGIT IPKTSSRAIT SPAGTADVME VLTNVELKEE EIKRIVKTTN GCLAWGGGVN LAPADDIIIN VERPVSIDPQ PQLLASVMAK KIATGIKYTV IDIPVGKGVK IKNEAEGAKL ARKFIELGEL LNIKVECVLT YGGQPLGRAI GPALEAREAI EALQDPKNAP KSLIEKALSL AGILLELGGA AQIGEGQKLA WEILESGRAL EKFNQIITEQ GGTPKKPEEI ELGEYVEEII APIDGYITDI SNTAITNVVK EAGAPRDKKA GILLNSKIGN QVKQGDILYT IYSGSEERLV SAVNLARRVY PVKVEGMLIE RISKF //